Business / Finance

RSS

Mylan enters settlement agreement with Pfizer for Caduet Tablets litigation

Mylan Inc. today announced that it has entered into a settlement agreement with Pfizer Inc. resolving litigation related to Caduet® Tablets, 2.5 mg/10, 2.5 mg/20 mg, 2.5 mg/40 mg, 5 mg/10 mg, 5 mg/20 mg, 5 mg/40 mg, 5 mg/80 mg, 10 mg/10 mg, 10 mg/20 mg, 10 mg/40 mg and 10 mg/80 mg, known generically as Amlodipine Besylate/Atorvastatin Calcium Tablets.

25 Jan 2011

Johnson & Johnson fourth quarter sales decreases 5.5% to $15.6 billion

Johnson & Johnson today announced sales of $15.6 billion for the fourth quarter of 2010, a decrease of 5.5% as compared to the fourth quarter of 2009. Operational sales declined 5.1% and the negative impact of currency was 0.4%. Domestic sales declined 8.1%, while international sales declined 3.1%, reflecting an operational decline of 2.3% and a negative currency impact of 0.8%.

25 Jan 2011

Corning fourth quarter sales increase 15% to $1.77 billion

Corning Incorporated today announced its results for the fourth quarter of 2010.

25 Jan 2011

Waters fourth quarter sales increase 13% to $484 million

Waters Corporation reported fourth quarter 2010 sales of $484 million, an increase of 13% from sales of $429 million in the fourth quarter of 2009. In the quarter, foreign currency translation was about neutral to sales growth. On a GAAP basis, earnings per diluted share (E.P.S.) for the fourth quarter were $1.36 compared to $1.08 for the fourth quarter of 2009.

25 Jan 2011

Cardo and Arthrex enter Asset Purchase Agreement

Cardo Medical, Inc., an orthopedic medical device company based in Los Angeles, California, its wholly-owned subsidiary, Cardo Medical, LLC, and Arthrex, Inc., a leading provider of sports medicine product development and educational services for orthopedic surgeons based in Naples, Florida, announced today that they signed an asset purchase agreement.

25 Jan 2011

Dr. Reddy’s third quarter consolidated revenues increase 10% to $424 million

Dr. Reddy's Laboratories Ltd. today announced its unaudited financial results for the quarter ended December 31st, 2010 under International Financial Reporting Standards (IFRS).

25 Jan 2011

Trust in business, government shows marked resilience: 2011 Edelman Trust Barometer

In a year marred by corporate crises and financial turmoil for European governments, trust in business and government showed marked resilience, according to the 2011 Edelman Trust Barometer. Trust in business saw a two-point global increase, surging in Brazil, rising in Germany, and holding steady in China and India. The United States was the outlier, as trust dropped across all institutions – business, government, NGOs, and media.

25 Jan 2011

Diamyd Medical reports first quarter group total net sales of MSEK 144.5

Diamyd completed screening for US Phase III study in type 1 diabetes. The screening of patients for the US Phase III study, DiaPrevent, was completed, ending the recruitment campaign. More than 310 recently diagnosed type 1 diabetes patients between 10 and 20 years of age had, at the completion of screening, been enrolled in the study and received their first injection of the antigen-based therapy Diamyd® or placebo.

25 Jan 2011

NEPAD, GAIN sign Memorandum of Understanding to reduce malnutrition in Africa

The Global Alliance for Improved Nutrition and the New Partnership for Africa Development today announced the signing of a Memorandum of Understanding to significantly contribute to reducing malnutrition in Africa.

25 Jan 2011

XIRING and SCM Microsystems enter strategic cooperation agreement

XIRING, a security solutions provider for electronic transactions, and SCM Microsystems, a business unit of Identive Group, Inc. and a global leader in security and identity solutions for secure access, secure identity and secure exchange, announced today that they have entered into a strategic cooperation agreement that expands their existing successful partnership.

25 Jan 2011

Myriant closes $60M strategic equity investment from PTT Chemical

Myriant Technologies, Inc., a privately-held, biotech developer and manufacturer of renewable bio-based chemicals, announced today the closing of a $60 million strategic equity investment from PTT Chemical Group, Thailand's largest petrochemical producer.

24 Jan 2011

NYSE Amex accepts Cardium's exchange listing compliance plan

Cardium Therapeutics reported that its exchange listing compliance plan submitted on December 2, 2010 has been accepted by the NYSE Amex LLC.

24 Jan 2011

PediatRx announces first-ever revenues and successful launch of GRANISOL

PediatRx Inc.is pleased to provide an update on activities for the fiscal third quarter. Among its achievements, the hospital specialty pharmaceutical company reported its first-ever revenues and successfully launched GRANISOL™, the company's first commercial entry.

24 Jan 2011

HealthStream, Laerdal launch Simcenter simulation management platform for healthcare institutions

Through their joint venture, SimVentures, HealthStream, Inc., a leading provider of learning and research solutions for the healthcare industry, and Laerdal Medical, a global leader in the provision of educational solutions for healthcare providers and educators, today announced the launch of SimCenter. The

From Laerdal 24 Jan 2011

Digital Assent closes $2 million Series A equity financing round

Atlanta-based Digital Assent, provider of the PatientPad self-service patient check-in and patient education solution, announces the closing of a $2 million Series A round of equity financing led by Imlay Investments, Fulcrum Equity Partners and BLH Venture Partners.

24 Jan 2011

American Scientific Resources now quoted on OTCQB market

American Scientific Resources, Inc. wishes to announces that it is now quoted on the OTCQB market.

24 Jan 2011

Hitachi Medical Systems America achieves top ranking among MRI vendors

In the 2010 Q4 User Satisfaction Survey, MD Buyline users have named Hitachi Medical Systems America (HMSA) the top rated MRI vendor. HMSA swept the top rankings in all six categories and earned a composite score 9.6 out of 10.

24 Jan 2011

Medisafe 1 Technologies' 2012 revenues to exceed $10M

Medisafe 1 Technologies Corp., a developer of patented technologies that physically prevent unauthorized administration of prescription medications, announced today that the company expects revenues in 2012 to exceed $10M .

24 Jan 2011

AnC Bio Holdings invests $4 million in Bioheart

Bioheart, Inc. announced today that it has entered into an agreement with AnC Bio Holdings, Inc., a South Korean biomedical company, and one of its U.S. agents for a $4 million equity investment. Bioheart has designated proceeds from the investment to advance the current clinical evaluation of its cell therapies for treating heart failure and related cardiac diseases.

24 Jan 2011

BDSI refutes MonoSol's patent infringement claims relating to BEMA Buprenorphine

BioDelivery Sciences International, Inc. today responded to a process patent infringement lawsuit filed and recently served against the Company and certain co-defendants by MonoSol Rx, LLC. The purpose in responding at this time is for BDSI to strongly refute MonoSol's claims and to assure BDSI stockholders that the Company remains focused on vigorously progressing its pipeline and not allowing this claim to present a distraction.

24 Jan 2011